跳至主要内容
临床试验/NCT05085678
NCT05085678已完成不适用

Development and Evaluation of a PROMs-based Interactive Programme as a Supporting Tool for Breast Cancer Patients Using Adjuvant Endocrine Therapy

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2020年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
77
试验地点
1
主要终点
Change in quality of Life - FACT-ES - B5 - H18

研究概览

简要总结

The objective of the study is to evaluate the effect of an online tool, based on patient reported outcomes (Co'moon), on the quality of life of breast cancer patients on adjuvant endocrine therapy in the University Hospital Leuven.

详细描述

The project aims to develop and evaluate an online programme to support patients with breast cancer on adjuvant endocrine therapy in the University Hospital Leuven. The tool "Co'moon" has been developed in the first phase of the project and secondly refine in a pilot study. In the third phase a randomised controlled study investigates the effect of Co'moon in comparison with the standard of care in the University Hospital Leuven. Hereby focussing on the improvement of self-efficacy en quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Older than 18 years
  • •Speaking, understanding and writing Dutch fluently
  • •Mentally competent
  • •Recently underwent a operation for breast cancer (invasive or in situ)
  • •Takes AET for maximum two months
  • •Consultation planned within 4-5 month
  • •Home access of a computer with internet connection

排除标准

  • •Different treatments regimes (e.g. adjuvant trial or a combination with cycline-dependent kinase (CDK) 4/6-inhibitors)
  • •Metastatic disease
  • •Inclusion Criteria health care professionals:
  • •Contact with patient(s) included in the trial
  • •Exclusion Criteria health care professionals:
  • •Included in panels
  • •Member of the research team

研究组 & 干预措施

Control group

No Intervention

Standard of care:

  • a short overview of the physician on adjuvant endocrine therapy
  • a brochure on adjuvant endocrine therapy
  • a voluntary group session on adjuvant endocrine therapy

and a monthly questionnaire on the patient reported outcomes

Intervention group

Experimental

Standard care with the access of to the online tool Co'moon and a monthly questionnaire on patient reported outcomes.

The outcome of the questionnaires are summarized for the physician to discuss during the follow-up consultation.

干预措施: Co'moon (online website to support women with AET) (Device)

结局指标

主要结局

Change in quality of Life - FACT-ES - B5 - H18

时间窗: monthly after two months of AET; up to 3 months

Total score of Functional Assessment of Chronic Illness Therapy system of Quality of Life questionnaires of endocrine symptoms (FACT-ES) combined with additional questions B5 and H18. A validated questionnaire with a 5-point Likert scale and a total score of 180 (high QoL).

Change in self-efficacy

时间窗: month 3 and 6 or 7 after the start with AET

patient reported impact on the side effects of AET

Therapy adherence

时间窗: monthly after two months of AET; up to 3 months

patient reported intentional or accidental forgot the medication

Questionnaire on patients experience with the patient-physician relationship

时间窗: month 6 or 7 after the start with AET

patient reported their experience of the follow-up consultation in a 5 point Likert scale questionnaire

Questionnaire on change in patient-relative communication over a period of +/- 3 months

时间窗: month 3 and 6 or 7 after the start with AET

patient reported a change in the communication of patients with their relatives in a 5 point Likert scale questionnaire

次要结局

  • Time-spend on Co'moon(up to 3 months)
  • Patient reported outcomes(Monthly after two months of AET; up to 3 months)
  • Questionnaire on the experience of the healthcare professional regarding the summary of PRO's(month 6 or 7 after the start of AET)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验